Please activate JavaScript!
Please install Adobe Flash Player, click here for download
ePaper created 2016-11-23, 14:26:06 | version 1.38.0
interview | 35 4 2016 implants quality and relevance to the market, which brings manybenefitstodoctorsandpatients.Thereisnoway to expect anything other than a very large market acceptance. Can you explain Optimum to us? Optimum is a project jointly developed between ZAPP and Klockner Implant System that started in 2012. In summary, it is a new way to treat titanium that allows to improve the mechanical properties of it.Asaconsequence,weareabletoprovidethemarket withallguaranteesforour3.0mmplatformswitching implant. What are the main requirements for Klockner when launching a new product? Therearetwomainpointsthatwewanttohighlight in all our products: quality and scientific rigor. Re- garding quality, our production features the lowest tolerances and adjustments on the market according to internal studies. With respect to science, we work on three important areas: a) Scientific support: We wanttobeknownasascientificcompanyandforthat we need that all our products to have scientific sup- port due to scientific publications in dental maga- zines. b) Product development: taking in to account theinputfromthemarket,universities,KOLandR&D, and based on the scietific literature we decide if we havetodevelopnewproductsforoursystemsornot. c) Innovation: like with ContacTi, our company is able to launch a 100 per cent original and unique product on the market. How do collaborations with external entities con- tribute to the development of new products? Sinceitsfoundation30yearsago,KlocknerImplant System has been renowned for investing in science, andwehavebeenworkingwithuniversitychairsfrom the very beginning. Today, we have five university chairs and more than 30 collaborations with other educational institutions. Without research in these institutions, there would be no other way to achieve the quality and scientific rigor of Klockner Implant Systemproducts.Weareproudtohavechairdirectors Dr Pablo Galindo (University of Granada), Dr Jose Maria Manero (UPC Barcelona), Dr José Nart (UIC Barcelona), Dr Pedro Bullón (Universidad Sevilla) and Dr Manuel Fernández (San Pablo CEU). What is the strategy of your company in terms of education? Every year, Klockner Implant System develops an education plan with more than 100 courses in dif- ferent formats, such as workshops, monographic courses,masters,clinicalcourses,participationinex- ternal events and organising small and large events such as Meeting Friends that, in 2015, received more than 1,000 attendees. In this sense, we are mainly striving for two things: to teach our customers how to get the maximum of versatility from our product portfolio, which is designed to provide solutions for all clinical cases in each phase of the treatment. We also seek to promote the constant development of dental medicine, helping doctors to update and im- prove their knowledge. Thank you for the interview._ contact Klockner Implant System—Soadco S.L. AVGDA. FITER I ROSSELL 4 BIS LOCAL 2 ESCALDES-ENGORDANY [AD700] PRINCIPAT D’ANDORRA Tel.: + 376 800.590 Fax: + 376 800.594 info@klocknerimplantsystem.com Fig. 3: The Klockner family with the Scientific Committee members and company owners Mercedes Roldán and Alejandro Padrós as well as Daniel Díez, the CEO of Spain and Portugal, during the launch of ContacTi in Barcelona in September. Fig. 3 42016 Tel.: + 376800.590 Fax: + 376800.594